NCT06331559 2026-02-09
Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Terminated
Jiangsu Simcere Pharmaceutical Co., Ltd.
Repare Therapeutics
Repare Therapeutics
AstraZeneca